Amini Alexandre | Medicine and Dentistry | Best Researcher Award

Dr. Amini Alexandre | Medicine and Dentistry | Best Researcher Award

MMED at Congo, Democratic Republic of the.

Dr. Amini Mitamo Alexandre is a dedicated medical professional from the Democratic Republic of Congo, specializing in urology and surgery. He serves as a Medical Doctor in Surgery at Cliniques Universitaires du Graben and holds a position as a Junior Lecturer in Medicine at Université Catholique du Graben. Dr. Alexandre is currently advancing his expertise by pursuing a Master of Medicine in Urology at Muhimbili University of Health and Allied Sciences in Tanzania. His research contributions are notable, with publications focusing on complex urological cases, including topics such as horseshoe kidney with ureteropelvic junction obstruction and adult Wilms tumor with inferior vena cava thrombus. Dr. Alexandre’s active involvement in professional organizations, such as the Société Internationale d’Urologie and the European Association of Urology, underscores his commitment to the global medical community. His dedication to both clinical practice and academic advancement positions him as a promising figure in the field of urology.

Professional Profile

Education

Dr. Alexandre’s educational journey began at Université Catholique du Graben in Butembo, North-Kivu, Democratic Republic of Congo, where he earned his MBBS in Medicine in 2018. Demonstrating a commitment to further specialization, he enrolled in the Master of Medicine program in Urology at Muhimbili University of Health and Allied Sciences in Dar es Salaam, Tanzania, in October 2021, with an expected completion date in August 2024. This advanced training reflects his dedication to enhancing his expertise in urological surgery and patient care.

Professional Experience

Since July 2019, Dr. Alexandre has been serving as a Medical Doctor specializing in Surgery at Cliniques Universitaires du Graben in Butembo. In this role, he has been actively involved in performing surgical procedures, managing patient care, and contributing to the development of surgical practices within the institution. In addition to his clinical responsibilities, he has been imparting medical knowledge as a Junior Lecturer in Medicine at Université Catholique du Graben since August 2018. His dual roles in clinical practice and academia highlight his commitment to advancing medical education and surgical excellence in his community.

Research Interests

Dr. Alexandre’s research interests are centered on urological disorders, surgical innovations, and public health challenges. He has conducted in-depth studies on complex urological conditions, contributing valuable insights into their management and treatment. His work aims to improve patient outcomes through the exploration of advanced surgical techniques and a better understanding of urological pathologies. By addressing both clinical and public health aspects, Dr. Alexandre strives to enhance the quality of healthcare services in his region and beyond.

Research Skills

Dr. Alexandre possesses a robust set of research skills, particularly in the design and execution of clinical studies focusing on urological conditions. His proficiency in data analysis and interpretation has enabled him to contribute to evidence-based practices in urology. He is adept at utilizing various research methodologies to explore complex medical cases, leading to publications in reputable medical journals. His ability to translate clinical observations into research findings demonstrates his commitment to advancing medical knowledge and improving patient care.

Awards and Honors

In recognition of his academic excellence and potential, Dr. Alexandre was honored with the BEBUC Award in 2014, a distinction that supports promising scholars in the Democratic Republic of Congo. This accolade facilitated his continued education and research endeavors. Further acknowledging his commitment to medical advancement, he was awarded a Master Fellowship through the BEBUC Scholarship Programme in October 2021. These honors reflect his dedication to contributing to the medical field and his potential for future leadership in healthcare.

Conclusion

Dr. Amini Mitamo Alexandre exemplifies a harmonious blend of clinical expertise, academic dedication, and research acumen. His comprehensive educational background, coupled with hands-on experience in surgery and medicine, underscores his commitment to advancing urological healthcare. His research endeavors, particularly in complex urological cases, contribute significantly to medical literature and practice. The awards and honors he has received are a testament to his potential and dedication to the medical profession. As he continues to evolve in his career, Dr. Alexandre is poised to make substantial contributions to urology and healthcare, both regionally and globally.

Publications Top Notes

  1. “Adult Wilms Tumor With Inferior Vena Cava Thrombus on an Incomplete Duplex Collecting System Ureter Fissus Proximalis Managed at a Tertiary Hospital in Tanzania: A Case Report and Literature Review”

    • Authors: Amini Mitamo Alexandre, Joseph Martin Lori, Gabriel F. Mtaturu, Victor Patrick Sensa, Sylvia Bedas Nsato, Mariam Athumani Mbezi, Obadia V. Nyongole, Charles A. Mkony
    • Year: 2025
  2. “Horseshoe Kidney Presenting With Features of Left Ureteropelvic Junction Obstruction—Insights Into Management: A Case Report and Review of the Literature”

    • Authors: Philipo Felix Mwita, Charles John Nhungo, Amini Mitamo Alexandre, Sylvia Bedas Nsato, Theofilo Mmbando, Gabriel Mtaturu, Obadia Nyongole, Charles A. Mkony
    • Year: 2025
  3. “Extent and Pattern of Symptom Relief Following Surgical Castration in Patients With Advanced Prostate Cancer Treated at a Tertiary Referral Hospital in Tanzania: A Prospective Cohort Study”

    • Authors: Charles John Nhungo, Victor Patrick Sensa, Fransia Arda Mushi, Amini Mitamo Alexandre, Kimu Marko Njiku, Ally Hamis Mwanga, Obadia Venance Nyongole, Alan Paciorek, Charles A. Mkony
    • Year: 2024
  4. “Persistent Ureteric Stump Syndrome Post Ureteric Re-implantation Following Impacted Distal Ureterolithiasis: Experience From Tertiary Hospital. Case Report”

    • Authors: Geofrey Chiloleti, Amini Mitamo Alexandre, Herry Kibona, Kimu Njiku, Isaack Mlatie, Fransia Mushi
    • Year: 2024
  5. “Isolated Testicular Tuberculosis Mimicking Testicular Malignancy in a 45-Year-Old Male Treated at a Tertiary Hospital: Case Report and Literature Review”

    • Authors: Sirili Aloyce Harya, Charles John Nhungo, Joseph Martin Lori, Amini Alexandre Mitamo, Charles A. Mkony, Praxeda Ogweyo
    • Year: 2024
  6. “Surgical Excision of Acquired Urethral Diverticulum and Single-Stage Urethroplasty for a 32-Year-Old Male: Case Report and Literature Review”

    • Authors: Charles John Nhungo, Amini Mitamo Alexandre, Fransia Arda Mushi, Kimu Marko Njiku, Ally Hamis Mwanga, Charles A. Mkony
    • Year: 2024
  7. “Encéphalocèle Occipitale et Anomalies Associées: Colobome Palpébral Bilatéral, Fente Labio-Palatine Bilatérale et Bride Amniotique sur la Jambe Droite avec Absence des Orteils sur Pieds Droit et Gauche aux Cliniques Universitaires du Graben Butembo 2021 (À Propos d’un Cas)”

    • Authors: Matthieu Aza Sumai, Alexandre Amini Mitamo, Joël Bosomi Yawi, Alpha Kavuyiro Muhindo, Jackson Musumba Kambale, Faida Muliwavyo Kavugho, Alexis Kahatane Kahindo, Claude Masumbuko Kasereka
    • Year: 2022
  8. “Analysis of Infant Mortality in Three Hospitals in the Eastern Democratic Republic of the Congo”

    • Authors: Not specified in the provided information
    • Year: 2018
  9. “High Prevalence of Transfusion-Transmissible Infections Among Volunteer Blood Donors in Rural Area of Eastern Democratic Republic of the Congo (D.R.C)”

    • Authors: Not specified in the provided information
    • Year: 2018
  10. “Epidemiological Profile and Risk Factors of Preterm Births in Two Referral Hospitals of Butembo, Eastern Democratic Republic of the Congo”

    • Authors: Not specified in the provided information
    • Year: 2018

 

Bin Wang | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Bin Wang | Medicine and Dentistry | Best Researcher Award

Professor at Southeast University, China

Prof. Wang Bin is a leading nephrology researcher, holding key academic and clinical leadership roles. His contributions include pioneering research, prestigious awards, competitive research funding, and influential committee memberships. With over 50 SCI-indexed publications, his work advances molecular diagnostics and therapies for chronic kidney disease and rare nephrological disorders. His impact extends beyond research, shaping policies and innovations in nephrology and artificial organ development.

Professional Profile

Research Leadership & Academic Roles

Prof. Wang Bin is a distinguished academic and researcher at Southeast University, serving as a Professor and Chief of the Youth Program. He holds key leadership positions as the Associate Chief Physician of the Department of Nephrology at Zhongda Hospital Affiliated with Southeast University, as well as the Deputy Director of both the Department of Nephrology and the Southeast University Kidney Disease Research Institute. As a PhD supervisor, he plays a pivotal role in mentoring the next generation of researchers in nephrology and kidney disease. His expertise extends to both clinical and research domains, ensuring a seamless integration of innovative scientific discoveries with patient care.

Awards & Recognitions

Prof. Wang has received numerous prestigious awards, reflecting his outstanding contributions to medical research. He has been recognized as a “Changjiang Scholar” Young Scholar by the Ministry of Education and a “Zhishan Scholar” of Southeast University. His excellence in nephrology research was further acknowledged when he won the Young Researcher Award at the 10th International Sarcopenia, Cachexia, and Wasting Disease (SCWD) Congress in Italy. Additionally, he has been honored with four provincial and ministerial-level awards, including being named among Jiangsu Province’s Top 10 Scientific and Technological Advancements, highlighting his impact on regional and national research initiatives.

Research Funding & Grants

Prof. Wang has demonstrated exceptional research capabilities by securing competitive funding from top-tier institutions. He has served as the principal investigator of four projects funded by the National Natural Science Foundation of China (NSFC), emphasizing his leadership in groundbreaking research. In addition, he has led one project under the Jiangsu Provincial Key Research and Development Program for Social Development and another under the Jiangsu Provincial Natural Science Foundation. His ability to attract such significant research grants underscores the importance and innovation of his work in nephrology, particularly in molecular diagnostics and treatment strategies for chronic kidney diseases and rare kidney disorders.

Publications & Scientific Contributions

With an extensive publication record, Prof. Wang has contributed over 50 SCI-indexed research articles in top-tier journals such as Journal of the American Society of Nephrology (JASN), Science Advances, Advanced Science, Diabetes, Molecular Therapy, and Kidney International Reports. His research findings have significantly advanced the understanding of chronic kidney disease (CKD) and rare nephrological disorders. As a first author or corresponding author (including co-corresponding roles), his work has gained widespread recognition in the medical and scientific communities. His research integrates cutting-edge molecular diagnostics with novel therapeutic strategies, making notable contributions to nephrology and biomedical sciences.

Committee Memberships & Academic Influence

Prof. Wang plays an active role in shaping nephrology research and policy by serving in various national and provincial medical committees. He is a committee member and academic secretary of the Artificial Organs Branch of the Chinese Society of Biomedical Engineering, contributing to advancements in artificial kidney development. Additionally, he is the Vice Chair of the Youth Group of the Nephrology Branch of the Chinese Medical Association (12th term) and the Youth Vice Chair of the 8th Kidney Disease Committee of the Jiangsu Provincial Association of Integrative Medicine. He also serves as a youth committee member of the Nephrology Branch of the Jiangsu Provincial Medical Association, further demonstrating his influence in nephrology research and clinical practice.

Research Focus & Future Prospects

Prof. Wang’s primary research focus is on molecular diagnostics and therapeutic strategies for muscle wasting in chronic kidney disease (CKD) and rare kidney diseases. His work has significantly contributed to understanding the mechanisms of muscle loss in CKD patients, paving the way for targeted therapeutic interventions. His studies also explore innovative treatment strategies for rare nephrological disorders, addressing critical gaps in kidney disease management. Looking ahead, his research could benefit from increased international collaborations, translational medicine initiatives, and the development of commercial medical applications. His contributions continue to shape the field of nephrology, positioning him as a leading researcher in kidney disease diagnostics and treatment.

Conclusion

Prof. Wang Bin is an outstanding researcher deserving of the Best Researcher Award for his exceptional contributions. His leadership, funding success, high-impact publications, and scientific influence make him a strong candidate. Expanding international collaborations and commercialization efforts could further enhance his research legacy and real-world impact.

Publication Top Notes

  1. Title: Photolithographic 3D SERS substrate via in-situ mineralization for optical anti-counterfeiting and ultra-trace analysis
    • Authors: Huang, K., Liu, H., Zhang, H., Jiang, H., Wang, X.
    • Journal: Chemical Engineering Journal
    • Year: 2025
    • Citations: 0
  2. Title: Therapeutic role of miR-26a on cardiorenal injury in a mice model of angiotensin-II induced chronic kidney disease through inhibition of LIMS1/ILK pathway
    • Authors: Ni, W., Zhao, Y., Shen, J., Wang, B., Liu, B.
    • Journal: Chinese Medical Journal
    • Year: 2025
    • Citations: 0
  3. Title: Duplex qPCR for detecting and differentiating porcine epidemic diarrhea virus GI and GII subtypes
    • Authors: Wang, B., Han, W., Wu, D., Wang, S., Wang, H.
    • Journal: Frontiers in Microbiology
    • Year: 2025
    • Citations: 0
  4. Title: Sacubitril/Valsartan for Blood Pressure Lowering in Non-Dialysis-Dependent Chronic Kidney Disease Stage 3–5 Patients With Hypertension: A Multicenter Clinical Study
    • Authors: Yan, Y., Li, X., Cao, J., Wan, X., Wang, B.
    • Journal: Journal of Clinical Hypertension
    • Year: 2025
    • Citations: 0
  5. Title: Efficacy of rituximab monotherapy in the treatment of adult minimal change disease
    • Authors: Wang, F., Wei, Q., Yang, Y., Zhang, X., Wang, B.
    • Journal: Chinese Journal of Nephrology
    • Year: 2024
    • Citations: 0
  6. Title: The gut microbiome, chronic kidney disease, and sarcopenia
    • Authors: Zheng, G., Cao, J., Wang, X.H., He, W., Wang, B.
    • Journal: Cell Communication and Signaling
    • Year: 2024
    • Citations: 0
  7. Title: CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer
    • Authors: Lu, K., Li, Z., Zhang, Q., He, W., Wang, B.
    • Journal: Scientific Reports
    • Year: 2024
    • Citations: 3
  8. Title: Research progress on inherited distal renal tubular acidosis due to variants of V-ATPase-related genes
    • Authors: Peng, S., Wu, Q., Yang, J., Wang, B., Zhang, X.
    • Journal: Chinese Journal of Medical Genetics
    • Year: 2024
    • Citations: 0
  9. Title: Identification of a Novel ECM Remodeling Macrophage Subset in AKI to CKD Transition by Integrative Spatial and Single-Cell Analysis
    • Authors: Zhang, Y., Tang, T., Wang, B., Lv, L., Liu, B.
    • Journal: Advanced Science
    • Year: 2024
    • Citations: 1
  10. Title: Tolvaptan and the role of kidney aquaporin-2 abundance in managing volume overload in patients with CKD
  • Authors: Yan, Y., Li, X., Yang, Y., Liu, B., Wang, B.
  • Journal: Clinical Kidney Journal
  • Year: 2024
  • Citations: 0

 

 

Hélène Laurent | Medicine and Dentistry | Women Researcher Award

Mrs. Hélène Laurent | Medicine and Dentistry | Women Researcher Award

Physiotherapist, Researcher at cancer center clermont auvergne metropolis, France.

Dr. Hélène Laurent is a distinguished physiotherapist and researcher specializing in respiratory and oncological rehabilitation. With a Doctorate in Life and Health Sciences, she has been actively involved in clinical care and scientific research for nearly two decades. She currently works at the Centre de Lutte Contre le Cancer Clermont Auvergne Métropole (Centre Jean Perrin), focusing on thoracic and endocrine surgery, as well as rehabilitation before cancer surgery. Her work includes developing innovative rehabilitation protocols for patients undergoing complex surgical treatments. Additionally, she is an esteemed member of several scientific societies, actively contributing to research coordination and ethical review committees. Dr. Laurent has published extensively in international journals, focusing on respiratory physiotherapy, perioperative rehabilitation, and exercise interventions for cancer patients.

Professional Profile

Education 🎓

Dr. Laurent pursued her academic journey with excellence. She obtained a Doctorate in Life and Health Sciences from Université Clermont Auvergne in 2020, earning the prestigious Prix de l’Ordre des Masseur-Kinésithérapeutes. Prior to that, she completed a Master’s in Exercise, Sport, Health, and Disability from Université Jean Monnet Saint-Etienne in 2015, graduating with honors. She further specialized in respiratory and cardiovascular physiotherapy through a diploma from Université Claude Bernard Lyon 1 in 2011, recognized with an award for best scientific publication. Her foundation in physiotherapy was laid at the Institut de Formation en Masso-Kinésithérapie Vichy, where she received her state diploma in 2006. Dr. Laurent’s commitment to lifelong learning has enabled her to become a leader in her field, integrating clinical expertise with cutting-edge research.

Experience 🏋️♀️

Dr. Laurent has an extensive professional background in both clinical and academic settings. Since 2022, she has been serving at the Centre de Lutte Contre le Cancer Clermont Auvergne Métropole (Centre Jean Perrin) as a thoracic and endocrine surgery specialist. Her role also involves managing a day hospital program for enhanced pre-surgical rehabilitation. Previously, from 2006 to 2022, she worked at CHU Gabriel Montpied in Clermont-Ferrand, where she was engaged in thoracic and cardiovascular surgery, pulmonology, and ICU rehabilitation. Beyond clinical practice, Dr. Laurent is actively involved in scientific research and academic teaching. She coordinates paramedical research projects, serves on ethics committees, and mentors students across multiple universities. Her experience in multi-disciplinary patient care and rehabilitation has positioned her as a leading expert in optimizing recovery pathways for surgical and critically ill patients.

Research Interests 🔬

Dr. Laurent’s research interests lie at the intersection of physiotherapy, respiratory care, and oncology. She focuses on prehabilitation strategies for patients undergoing lung cancer surgery, investigating the role of exercise in improving postoperative outcomes. Her work also explores ventilatory restriction management, respiratory muscle training, and early mobilization in intensive care units. Dr. Laurent has played a pivotal role in developing decisional algorithms for tailoring exercise programs to individual patient needs. Additionally, she is actively engaged in studying the impact of oxidative stress, nutrition, and physical activity on lung cancer progression. Her research aims to bridge the gap between physiotherapy and oncology, fostering interdisciplinary approaches to patient-centered rehabilitation.

Awards & Recognitions 🏆

Dr. Laurent has received several prestigious awards in recognition of her contributions to physiotherapy and rehabilitation sciences. In 2020, she was honored with the Prix de l’Ordre des Masseur-Kinésithérapeutes for her doctoral research in life and health sciences. She also received the Jury Prize from the departmental committee of La Ligue Contre le Cancer in 2021 for her outstanding work in oncological rehabilitation. In 2012, her article on respiratory physiotherapy was awarded the Best Scientific Article Prize by Kinésithérapie La Revue. These accolades underscore her commitment to advancing physiotherapy research and improving clinical outcomes for patients with complex medical conditions.

Top Noted Publications 📚

Dr. Laurent has an extensive publication record in high-impact scientific journals. Below are some of her key publications:

  • Laurent H. (2023). “Activité physique et cancer broncho-pulmonaire : Synthèse de la littérature.” Revue des Maladies Respiratoires, 40, 406-415. [Cited by 5]
  • Laurent H. (2023). “Trouble ventilatoire restrictif: Prise en charge.” In: Reychler G, et al. Kinésithérapie cardiorespiratoire. Elsevier Masson. [Cited by 3]
  • Laurent H., Gravier FE. (2022). “Préparation à une chirurgie thoraco-abdominale.” Revue des Maladies Respiratoires, 39(4), 376-385. [Cited by 7]
  • Laurent H., Aubreton S., et al. (2020). “Very early exercise tailored with a decisional algorithm relieves discomfort in ICU patients.” Eur J Phys Rehabil Med, 56(6), 756-763. [Cited by 12]
  • Laurent H., Galvaing G., et al. (2020). “Preoperative respiratory muscle endurance training improves ventilatory capacity.” Eur J Phys Rehabil Med, 56(1), 73-81. [Cited by 15]
  • Laurent H., Aubreton S., et al. (2017). “Effect of an intensive 3-week preoperative home rehabilitation program for lung cancer patients.” BMJ Open, 7(11), e017307. [Cited by 20]

Conclusion

Dr. Hélène Laurent is a strong candidate for the Research for Women Researcher Award due to her significant contributions to medical research, education, and clinical practice. Her work in oncology rehabilitation and respiratory therapy demonstrates impactful advancements in patient care. Strengthening international collaborations and securing independent grants could further solidify her eligibility.

 

Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Dr. Victoria Ramos | Smart Health | Global Health Impact Award

Dr. Victoria Ramos | Smart Health | Global Health Impact Award

Científica Titular de OPI at Smart Health , Instituto de Salud Carlos III , Spain

👨‍🎓She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

A. Previous Activities: They served as the Chief of the Geology Service (Petrography – Mineralogy) at the Regional Laboratory of the Mining Research Company, South Division, Tamanrasset, in 1988 and 1989. B. Recruitment at the University: They were recruited on September 11, 1989, as a Teacher in the Department of Geology at the Faculty of Earth Sciences.

Activities:

In the classic system (1989-2010):

  • Fundamental Geochemistry
  • Petrology of Metamorphic Terrains
  • Mineralogy
  • Thermodynamics

In the LMD system (since 2010):

  • Bachelor’s Level:
    • Global Geodynamics and Metamorphism
    • Geochemistry of the Earth
    • Geochemistry of Natural Gases and Organic Geochemistry
    • Stable Isotopes

Administrative:

  • Acting as the Head of the Mining Geology Department
  • Overseeing field internships for students
  • Participating in several university research projects (Project No. G2301/01/91 from 1991 to 1995; Project No. G2301/05/98 from 1998 to 2000; Project No. F2301/02/2002 from 2001 to 2005)
  • Leading the research project with the code G2301/09/2005, as well as three other projects since 2005
  • Serving as a member of the organizing committee for the Maghreb Seminar on Earth Sciences at the University of Annaba in 1994
  • Being involved in the ANDRS research project from 2000 to 2004
  • Acting as a member of the scientific committee for the National Seminar on Earth Sciences in Tlemcen, October 199

Publications:

Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy

The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction

Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein

Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: A new pathway to induce cardiac damage

A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts

Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity

Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats

MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats | El impacto de la obesidad sobre el lipidoma cardiaco y sus consecuencias en el daño cardiaco en ratas obesas

The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

Mr. Waseem Ali | Drug Repurposing | Best Researcher Award

Mr. Waseem Ali : Leading Researcher in Drug Repurposing

PhD Student at Drug Repurposing, Guru Nanak Dev Engineering College, Ludhiana, Punjab, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Waseem Ali achieved academic success throughout his educational journey. In 2011, he secured a First Division in the Matriculation examination from the C.B.S.E. Board, India, with a focus on Science. Continuing his impressive performance, he obtained a Second Division in the Higher Secondary examination in 2013 from the same board. In 2016, he graduated with a Second Division from C.C.S. University, Meerut, specializing in Biotechnology with a focus on molecular biology. His commitment to excellence was further demonstrated in 2018 when he completed his Post Graduation with a First Division from Jamia Hamdard, New Delhi, specializing in Biotechnology with a focus on molecular biology.

Experience:

Mr. Waseem Ali has held several positions in the field of Biotechnology and molecular biology. From 05-08-2022 to 29-12-2022, he served as a Project Assistant at Jamia Hamdard, where he contributed to a project aiming to decipher novel targets of M.tb pathogenesis that manipulate host defenses in compromised hosts. The identified targets may be utilized to develop anti-TB agents effective against drug-resistant isolates. His supervisor during this time was Dr. Javaid A Shaikh. Prior to this, from 15-01-2019 to 04-08-2022, Mr. Ali worked as a Project Assistant at Jamia Hamdard, focusing on determining the effect of FDA-approved drugs against M.tb. He evaluated the efficacy of selected drugs against M.tb in vitro and ex vivo, using molecular docking, simulation, and biophysical methods to predict their binding affinity and effect with target proteins. His supervisors during this period were Prof. S. E. Hasnain and Dr. Sonam Grover. Currently, since 04-01-2021, Mr. Ali is pursuing his Ph.D. at Jamia Hamdard under the guidance of Prof. S. E. Hasnain and Dr. Sonam Grover, focusing on research related to drug repurposing.

Publications:

Mr. Waseem Ali has co-authored several research papers in reputable journals. In “Microbes and Infection” in 2023, he collaborated with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Isha Pahuja, Rahul Sharma, Ved Prakash Dwivedi, Meetu Agarwa, and Sonam Grover on a paper titled “Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA,” which was published on 5.8. In “Molecular Informatics” in 2023, he worked with Salma Jamal, Rishabh Gangwar, Faraz Ahmed, Rahul Sharma, Meetu Agarwal, Javaid Ahmad Sheikh, Abhinav Grover, and Sonam Grover on a paper titled “Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors,” which was published on 4.05. Additionally, in “Computational and Structural Biotechnology Journal” in 2021, he contributed to a paper titled “Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis,” co-authored with Pooja Singh, Salma Jamal, Faraz Ahmed, Najumu Saqib, Seema Mehra, Deodutta Roy, Nasreen Z Ehtesham, and Seyed E Hasnain. In “Journal of Translational Medicine” in 2021, Mr. Ali collaborated with Salma Jamal, Priya Nagpal, Abhinav Grover, and Sonam Grover on a paper titled “Computational models for the prediction of adverse cardiovascular drug reactions,” which was published on 8.44.

 

Mr. Rahul Sharma | Molecular Medicine | Best Researcher Award

Mr. Rahul Sharma : Leading Researcher in Molecular Medicine

PhD Scholar at Molecular Medicine, Jamia Hamdard, India

He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Mr. Rahul Sharma is a dedicated researcher with expertise in molecular medicine and biotechnology. In 2023, he submitted his Ph.D. thesis in Molecular Medicine at Jamia Hamdard, New Delhi. His research focused on drug repurposing approaches against methyltransferases of Mycobacterium tuberculosis and alternative therapeutics, under the supervision of Dr. Sonam Grover. Prior to his Ph.D., Mr. Sharma completed his MS in Biotechnology at Jamia Hamdard in 2017. His master’s thesis titled “Molecular characterization and phylogenetic analysis of Rotavirus A, G9 with different P-type combinations including Rotavac vaccine strain G9P[11], 116E” was conducted under the guidance of Professor Pratima Ray. His academic journey reflects a strong commitment to advancing knowledge in the field of molecular medicine and biotechnology. Mr. Rahul Sharma is a researcher specializing in molecular medicine and biotechnology. In 2023, he completed his Ph.D. in Molecular Medicine at Jamia Hamdard, New Delhi, where he focused on drug repurposing approaches against methyltransferases of Mycobacterium tuberculosis and alternative therapeutics. This significant research was conducted under the guidance of Dr. Sonam Grover. Prior to his Ph.D., Mr. Sharma earned his MS in Biotechnology from Jamia Hamdard in 2017. His master’s thesis, supervised by Professor Pratima Ray, was titled “Molecular characterization and phylogenetic analysis of Rotavirus A, G9 with different P-type combinations including Rotavac vaccine strain G9P[11], 116E.” Mr. Sharma’s academic journey showcases his dedication to advancing the field of molecular medicine and biotechnology through rigorous research.

Experience:

In his primary research work, Mr. Rahul Sharma conducted screenings of FDA-approved drugs using computational and biophysical methods against essential enzymes of Mycobacterium tuberculosis. Selected compounds from this screening were then tested for their inhibitory potential on the virulent strain Mtb-H37Rv under both in-vitro and ex-vivo conditions. In his secondary research work, Mr. Sharma focused on immunoinformatics to design a vaccine construct aimed at preventing and treating Mycobacterium tuberculosis infections. This vaccine construct was designed based on the analysis of secretory exosomes antigens of the pathogen, with the goal of developing a preventive therapeutic approach against tuberculosis.

Area of Specialization:

  1. Molecular Cloning
  2. Recombinant protein production
  3. Fluorescence spectroscopy
  4. High-throughput ligand and buffer screening
  5. Protein-ligand interaction thermodynamics
  6. Protein folding and unfolding
  7. Molecular dynamic simulations
  8. Computational Structure-based drug design
  9. Molecular mechanical calculations
  10. Peptide-based vaccine design

Technical skills:

Mr. Rahul Sharma demonstrates proficiency in a variety of technical skills relevant to his research in molecular medicine and biotechnology:

  • Operating Systems: He is experienced in working with UNIX (Ubuntu) and Windows operating systems, showcasing adaptability across different platforms.
  • Programming Languages: He has a foundational understanding of Bash and Python programming languages, which are commonly used in bioinformatics and computational biology.
  • Molecular Dynamics: Mr. Sharma has expertise in using GROMACS for simulating protein-ligand and protein-protein interactions, as well as DESMOND for molecular dynamics simulations.
  • Docking Software: He is skilled in using GLIDE and VINA for molecular docking studies, a crucial aspect of drug discovery and development.
  • Purification Techniques: Mr. Sharma is proficient in the use of Nickel-NTA His-tag affinity chromatography for protein purification, a key step in obtaining high-quality protein samples.

Awards:

Mr. Rahul Sharma has received prestigious accolades and awards that underscore his exceptional contributions and achievements in the field of biotechnology and molecular medicine:

  • 2020 Senior Research Fellowship (SRF), Department of Biotechnology, Government of India: Recognition of his advanced research capabilities and significant contributions to the field, awarded by the esteemed Department of Biotechnology, Government of India.
  • 2018 Junior Research Fellowship (JRF), Department of Biotechnology, Government of India: Acknowledgment of his research potential and early accomplishments in the field, awarded by the Department of Biotechnology, Government of India.
  • 2018 Award for Assistant Professorship, Agricultural Scientists Recruitment Board (ASRB), Government of India: Recognition of his potential for an academic career and teaching excellence, awarded by the Agricultural Scientists Recruitment Board (ASRB), Government of India.